Projects per year
Search results
-
Active
-
Phase III_Parsaclisib and Ruxolitinib_Myelofibrosis_INCB 50465-313 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Combination of PI3K Inhibitor Parsaclisib and Ruxolitinib in Participants With Myelofibrosis
Shah, S., Ganguly, S., Petkova, J., Pingali, S. R. & Rice, L.
8/23/21 → …
Project: Clinical Trial
-
Sepsis Prediction with Deep Learning and Wearable Monitoring Patch'd
Pingali, S. R., Ganguly, S., Gotur, D. B., Jones, S. L., Masud, F. N. & Shah, S.
7/14/21 → …
Project: Clinical Trial
-
Phase 3_NavitoclaxRuxolitinib_Myelofibrosis_Abbvie M20-178 Transform-2
Shah, S., Ganguly, S., Pingali, S. R. & Rice, L.
6/7/21 → …
Project: Clinical Trial